摘要
目的回顾分析近6年广州血液中心临床供血量,掌握广州市临床供血整体水平,预测供血趋势,促进医院合理、科学使用血液提供资料。方法收集2012—2017年广州血液中心临床供血资料,以全血、成分血(红细胞类、血浆类、单采血小板、浓缩血小板和冷沉淀)为统计对象进行分析。结果近6年共为临床供应5 332 672.25 U血液制品,全血供应3 341U,占0.06%,成分血供应5 329 331.25 U,占99.94%,其中红细胞类、血浆、血小板呈逐年增长趋势,冷沉淀供应量波动较大。结论 2012—2017年临床供血量及增长速度逐年增长,成分血占绝对优势,成分输血理念深入临床,科学、合理用血既可保障输血安全、有效,也可缓解供血压力。
Objective To retrospective analyze the clinical blood supply in Guangzhou Blood Center in the past six years to extract overall clinical blood use status and predict future consumption with rational and scientific blood use. Methods The data of clinical blood supply including whole blood and blood components(erythrocytes, plasma, platelet and cryoprecipitate) in Guangzhou Blood Center from 2012 to 2017 was collected and analyzed. Results Guangzhou Blood Center delivered 5 332 672.25 U of blood products for clinical use in the last six years. The whole blood was 3 341 U, accounting for 0.06%;The blood components were 5 329 331.25 U, accounting for 99.94%. Erythrocytes, plasma and platelet consumptions kept increasing year by year while cryoprecipitate supply had some fluctuations. Conclusion Both the volume and increasing rates of blood demand show rapid rise in the past 6 years. Blood component transfusion was the dominant component and the popular choice in hospitals, which was a direct reflection of rational and scientific blood use, ensuring transfusion safety as well as reliving blood supply pressure in certain regions.
作者
游冉冉
罗伟峰
林永桔
滕青
张旸
汪传喜
YOU Ranran;LUO Weifeng;LIN Yongju;TENG Qing;ZHANG Yang;WANG Chuanxi(Guangzhou Blood Center,Guangzhou 510095,China)
出处
《中国输血杂志》
CAS
2018年第12期1393-1395,共3页
Chinese Journal of Blood Transfusion
基金
广州市医药卫生重大项目(20161A031003)
关键词
临床供血
输血安全
供血增长速度
成分输血
blood supply
blood transfusion safety
growth rate
blood component transfusion
作者简介
第一作者:游冉冉;第一作者:罗伟峰;通信作者:汪传喜(1962.10-),男,主任医师,主要从事采供血业务管理及研究工作,电话:020-83596185,Email:callmm@126.com
